ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 125347 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 125347; 2) Community: the network communities that were significantly associated with the response to NSC 125347; 3) Molecule: the relationships between components within communities and NSC 125347; 4) MDR: the compounds that were significantly associated with the NSC 125347.

NSC Compound Enrichment Correlation
NSC 90810 Null 0.0241085022307781 -0.02599276
NSC 100046 Elephantopin 0.0244632509325736 0.26648781
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.0244632509325736 0.28969339
NSC 113951 6-Bromotoyocamycin 0.0244632509325736 0.34250055
NSC 180198 Hydrazinecarbothioamide, 2,2'-(1,5-dimethyl-1,5-pentanediylidene)bis[N-methyl- 0.0244632509325736 0.3410185
NSC 294526 Null 0.0244632509325736 0.28016243
NSC 354671 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2- thiazolyl)ethylidene]hydrazide 0.0244632509325736 0.3957142
NSC 363812 Tetraplatin 0.0244632509325736 0.51790699
NSC 621336 Null 0.0244632509325736 0.28144202
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0244632509325736 0.32324226
Total:78  Current:43    [First] [Prev] [Next] [Last]